Radiogenomics identifying important biological pathways in gliomas.
作者信息
Jain Rajan, Chi Andrew S
机构信息
Department of Radiology, New York University Grossman School of Medicine, New York, New York, USA.
Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York, USA.
出版信息
Neuro Oncol. 2021 Feb 25;23(2):177-178. doi: 10.1093/neuonc/noaa290.
Abstract
摘要
相似文献
1
Radiogenomics identifying important biological pathways in gliomas.放射基因组学鉴定神经胶质瘤中的重要生物学通路。
Neuro Oncol. 2021 Feb 25;23(2):177-178. doi: 10.1093/neuonc/noaa290.
2
Radiogenomics of Gliomas.脑胶质瘤的放射组学
Radiol Clin North Am. 2021 May;59(3):441-455. doi: 10.1016/j.rcl.2021.02.002.
3
iGLASS: imaging integration into the Glioma Longitudinal Analysis Consortium.iGLASS：将成像整合到胶质瘤纵向分析联盟中。
Neuro Oncol. 2020 Oct 14;22(10):1545-1546. doi: 10.1093/neuonc/noaa160.
4
Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data.通过对微阵列数据的生物信息学分析揭示胶质瘤和神经胶质瘤发病机制的分子机制。
Med Oncol. 2017 Sep 26;34(11):182. doi: 10.1007/s12032-017-1043-x.
5
Long Non-Coding RNAs in Gliomas: From Molecular Pathology to Diagnostic Biomarkers and Therapeutic Targets.长链非编码 RNA 在脑胶质瘤中的研究进展：从分子病理学到诊断标志物和治疗靶点。
Int J Mol Sci. 2018 Sep 13;19(9):2754. doi: 10.3390/ijms19092754.
6
Comparison of Genetic Profiles and Prognosis of High-Grade Gliomas Using Quantitative and Qualitative MRI Features: A Focus on G3 Gliomas.利用定量和定性 MRI 特征比较高级别脑胶质瘤的遗传谱和预后：聚焦 G3 级胶质瘤。
Korean J Radiol. 2021 Feb;22(2):233-242. doi: 10.3348/kjr.2020.0011. Epub 2020 Sep 10.
7
Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness.5'-甲基硫腺苷磷酸化酶（MTAP）缺失在高级别胶质瘤中很常见；然而，它与更高的肿瘤侵袭性无关。
Cells. 2020 Feb 20;9(2):492. doi: 10.3390/cells9020492.
8
[Correlation between genetic alterations and clinical outcomes in malignant gliomas; especially glioblastoma].恶性胶质瘤尤其是胶质母细胞瘤中基因改变与临床结局的相关性
Gan To Kagaku Ryoho. 2014 Jun;41(6):713-9.
9
Enrichment of branched chain amino acid transaminase 1 correlates with multiple biological processes and contributes to poor survival of IDH1 wild-type gliomas.支链氨基酸转氨酶 1 的富集与多种生物学过程相关，并且与 IDH1 野生型脑胶质瘤患者的不良预后相关。
Aging (Albany NY). 2021 Jan 20;13(3):3645-3660. doi: 10.18632/aging.202328.
引用本文的文献
1
Radiomics in glioma: emerging trends and challenges.神经胶质瘤中的放射组学：新趋势与挑战
Ann Clin Transl Neurol. 2025 Mar;12(3):460-477. doi: 10.1002/acn3.52306. Epub 2025 Feb 3.
2
Bridging the Gap Between Imaging and Molecular Characterization: Current Understanding of Radiomics and Radiogenomics in Hepatocellular Carcinoma.弥合成像与分子特征之间的差距：肝细胞癌中放射组学和放射基因组学的当前认识
J Hepatocell Carcinoma. 2024 Nov 27;11:2359-2372. doi: 10.2147/JHC.S423549. eCollection 2024.
3
Advances on Liquid Biopsy Analysis for Glioma Diagnosis.用于神经胶质瘤诊断的液体活检分析进展
Biomedicines. 2023 Aug 24;11(9):2371. doi: 10.3390/biomedicines11092371.
4
Combination of multi-modal MRI radiomics and liquid biopsy technique for preoperatively non-invasive diagnosis of glioma based on deep learning: protocol for a double-center, ambispective, diagnostical observational study.基于深度学习的多模态MRI影像组学与液体活检技术联合用于胶质瘤术前无创诊断：一项双中心、双向、诊断性观察研究方案
Front Mol Neurosci. 2023 May 2;16:1183032. doi: 10.3389/fnmol.2023.1183032. eCollection 2023.
5
Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.基于液体活检和放射基因组学的胶质瘤术前诊断及分子特征分析
Front Neurol. 2022 May 26;13:865171. doi: 10.3389/fneur.2022.865171. eCollection 2022.
6
Applications of Radiomics and Radiogenomics in High-Grade Gliomas in the Era of Precision Medicine.精准医学时代下放射组学和放射基因组学在高级别胶质瘤中的应用
Cancers (Basel). 2021 Nov 25;13(23):5921. doi: 10.3390/cancers13235921.
7
A Comprehensive Review on Radiomics and Deep Learning for Nasopharyngeal Carcinoma Imaging.鼻咽癌成像的放射组学与深度学习综合综述
Diagnostics (Basel). 2021 Aug 24;11(9):1523. doi: 10.3390/diagnostics11091523.
本文引用的文献
1
Sexually dimorphic radiogenomic models identify distinct imaging and biological pathways that are prognostic of overall survival in glioblastoma.性别二态性放射基因组学模型确定了与胶质母细胞瘤总生存期相关的不同影像学和生物学途径。
Neuro Oncol. 2021 Feb 25;23(2):251-263. doi: 10.1093/neuonc/noaa231.
2
A systematic review reporting quality of radiomics research in neuro-oncology: toward clinical utility and quality improvement using high-dimensional imaging features.系统评价报告神经肿瘤学中放射组学研究的报告质量：利用高维成像特征实现临床应用和质量改进。
BMC Cancer. 2020 Jan 10;20(1):29. doi: 10.1186/s12885-019-6504-5.
3
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data.基于患者影像、转录组和生存数据的分析揭示胶质母细胞瘤中的性别差异。
Sci Transl Med. 2019 Jan 2;11(473). doi: 10.1126/scitranslmed.aao5253.
4
How Far Are We from Using Radiomics Assessment of Gliomas in Clinical Practice?我们距离在临床实践中使用胶质瘤的放射组学评估还有多远？
Radiology. 2018 Dec;289(3):807-808. doi: 10.1148/radiol.2018182033. Epub 2018 Oct 2.
5
Females have the survival advantage in glioblastoma.女性在胶质母细胞瘤中具有生存优势。
Neuro Oncol. 2018 Mar 27;20(4):576-577. doi: 10.1093/neuonc/noy002.
6
Radiomics: the bridge between medical imaging and personalized medicine.放射组学：医学影像与个性化医疗之间的桥梁。
Nat Rev Clin Oncol. 2017 Dec;14(12):749-762. doi: 10.1038/nrclinonc.2017.141. Epub 2017 Oct 4.
7
Sex-specific clinicopathological significance of novel (Frizzled-7) and established (MGMT, IDH1) biomarkers in glioblastoma.新型生物标志物（卷曲蛋白-7）和已确立的生物标志物（O6-甲基鸟嘌呤-DNA甲基转移酶、异柠檬酸脱氢酶1）在胶质母细胞瘤中的性别特异性临床病理意义
Oncotarget. 2016 Aug 23;7(34):55169-55180. doi: 10.18632/oncotarget.10465.
8
Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.分子分析揭示弥漫性胶质瘤的生物学离散亚群和进展途径。
Cell. 2016 Jan 28;164(3):550-63. doi: 10.1016/j.cell.2015.12.028.
9
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.放疗联合同步及辅助替莫唑胺治疗胶质母细胞瘤
N Engl J Med. 2005 Mar 10;352(10):987-96. doi: 10.1056/NEJMoa043330.
Zotero 插件